A Comparative Expected Value Analysis Study to Determine If the Economic Benefits of the Most Commonly Prescribed Prescription and Non-Prescription Drugs in the United States Provide Economic Value

Economic value, anti-biotics, aspirin, bisphosphonates, blood pressure, statins, diabetes, sexual dysfunction, poly-pill, Alzheimer’s, cancer, multiple sclerosis, Clopidogrel, weight-loss.

Authors

October 7, 2021
October 7, 2021

Downloads

It was found that anti-biotics, aspirin, bisphosphonates, blood pressure lowering medications, statins, medications treating depression, diabetes, sexual dysfunction and the poly-pill provided economic value, while medications to treat Alzheimer’s, cancer, multiple sclerosis and Clopidogrel were not found to have provided economic value. The current evidence is insufficient to determine if weight loss medication provides economic value or not